Game Plan Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Game Plan Financial Advisors's REGN Position: Q2 2026 in Review
Game Plan Financial Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q2 2026, selling an estimated $22.5K and leaving 82 shares worth $51.3K. The position accounts for 0.02% of the portfolio, ranked #141.
Game Plan Financial Advisors first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $121K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Game Plan Financial Advisors held 82 shares of Regeneron Pharmaceuticals worth $51.3K as of Q2 2026.
- Game Plan Financial Advisors sold 33 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
- Regeneron Pharmaceuticals made up 0.02% of Game Plan Financial Advisors's portfolio in Q2 2026, its #141 holding.
- Game Plan Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- Game Plan Financial Advisors's Regeneron Pharmaceuticals position peaked at $121K in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Game Plan Financial Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.